Involvement of FrzA/sFRP-1 and the Wnt/frizzled pathway in ischemic preconditioning
Involvement of FrzA/sFRP-1 and the Wnt/frizzled pathway in ischemic preconditioning
复制标题
DOI:
10.1161/01.res.0000171895.06914.2c
复制
发表时间:
2005-06-24
影响因子:
20.1
通讯作者:
Duplàa, C
中科院分区:
文献类型:
--
作者:
Barandon, L;Dufourcq, P;Duplàa, C
Phosphorylation and subsequent inactivation of glycogen synthase kinase (GSK)-3 beta via the Akt/PI3-Kinase pathway during ischemic preconditioning (PC) has been shown to be cardioprotective. As FrzA/sFRP-1, a secreted antagonist of the Wnt/Frizzled pathway, is expressed in the heart and is able to decrease the phosphorylation of GSK-3 beta in vitro on vascular cells, we examined its effect during PC using transgenic mouse overexpressing FrzA in cardiomyocytes (alpha-MHC promoter) under a conditional transgene expression approach (tet-off system). Overexpression of FrzA inhibited the increase in GSK-3 beta phosphorylation as well as protein kinase C (PKC) epsilon activation in transgenic mice after PC as compared with littermates. Phospho-Akt (P-Akt), phospho-JNK, or the cytoplasmic beta-catenin levels were not modified, phospho-p38 (P-p38) was slightly increased in transgenic mice after PC as compared with littermates. FrzA transgenic mice displayed a larger infarct size and a greater worsening of cardiac function compared with littermates. All these differences were reversed by the addition of doxycycline. This study demonstrates for the first time that disruption of a beta-catenin independent Wnt/Frizzled pathway induces the activation of GSK-3 beta and reverses the benefit of preconditioning.